With 0.68 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.69 million shares. The 52-week range on CDXS shows that it touched its highest point at $6.08 and its lowest point at $2.56 during that stretch. It currently has a 1-year price target of $7.14. Beta for the stock currently stands at 2.08.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CDXS was up-trending over the past week, with a rise of 1.95%, but this was down by -14.17% over a month. Three-month performance surged to 6.36% while six-month performance rose 40.74%. The stock gained 44.64% in the past year, while it has lost -12.37% so far this year. A look at the trailing 12-month EPS for CDXS yields -0.88 with Next year EPS estimates of -0.69. For the next quarter, that number is -0.04. This implies an EPS growth rate of 29.13% for this year and 13.43% for next year. EPS is expected to grow by 27.32% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -39.95%.
Float and Shares Shorts:
At present, 81.38 million CDXS shares are outstanding with a float of 79.15 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CDXS since 3 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.72159 being high and -$0.91745 being low. For CDXS, this leads to a yearly average estimate of -$0.79375. Based on analyst estimates, the high estimate for the next quarter is -$0.14 and the low estimate is -$0.19. The average estimate for the next quarter is thus -$0.17.